Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer

Technology appraisal guidance
Reference number: TA100
Published: 26 April 2006

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive
04 July 2011
(58.63 Kb 17 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 04 July 2011